FDA
- Status: approved
🇺🇸 Rimegepant 75mg every other day dosing in United States
Rimegepant 75mg every other day dosing (rimegepant-75mg-every-other-day-dosing) regulatory status in United States.
Marketing authorisation
Pricing & reimbursement
- annual_list: USD 2869.00 per year
Rimegepant 75mg every other day dosing in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Rimegepant 75mg every other day dosing approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Rimegepant 75mg every other day dosing in United States?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.
What does Rimegepant 75mg every other day dosing cost in United States?
annual_list: USD 2869.00 per year. Final patient cost depends on reimbursement and any patient access scheme.